These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8383621)

  • 1. Subacute toxicity of a novel inhibitor of acyl-CoA: cholesterol acyltransferase in beagle dogs.
    Dominick MA; McGuire EJ; Reindel JF; Bobrowski WF; Bocan TM; Gough AW
    Fundam Appl Toxicol; 1993 Feb; 20(2):217-24. PubMed ID: 8383621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD 132301-2, an inhibitor of acyl-CoA:cholesterol acyltransferase.
    Dominick MA; Bobrowski WA; MacDonald JR; Gough AW
    Toxicol Pathol; 1993; 21(1):54-62. PubMed ID: 8397438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicologic effects of a novel acyl-CoA:cholesterol acyltransferase inhibitor in cynomolgus monkeys.
    Reindel JF; Dominick MA; Bocan TM; Gough AW; McGuire EJ
    Toxicol Pathol; 1994; 22(5):510-8. PubMed ID: 7899779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical safety evaluation of avasimibe in beagle dogs: an ACAT inhibitor with minimal adrenal effects.
    Robertson DG; Breider MA; Milad MA
    Toxicol Sci; 2001 Feb; 59(2):324-34. PubMed ID: 11158726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic and adrenal toxicity of a novel lipid regulator in beagle dogs.
    Wolfgang GH; Robertson DG; Welty DF; Metz AL
    Fundam Appl Toxicol; 1995 Jul; 26(2):272-81. PubMed ID: 7589916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
    Kashiwa M; Masuyama Y; Miyauchi H; Uchida T; Naganuma S; Kakuta H; Terada M; Kiriyama T; Matsuda K; Ito N; Iizumi Y; Takenaka T
    Jpn J Pharmacol; 1997 Jan; 73(1):41-50. PubMed ID: 9032133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACAT-selective and nonselective DGAT1 inhibition: adrenocortical effects--a cross-species comparison.
    Floettmann JE; Buckett LK; Turnbull AV; Smith T; Hallberg C; Birch A; Lees D; Jones HB
    Toxicol Pathol; 2013; 41(7):941-50. PubMed ID: 23427273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of compound X, a novel potent inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase, on the adrenal gland of rats.
    Nishimura J; Ohmichi K; Wato E; Saito T; Takashima K; Tanaka T; Hiwatashi Y; Kobayashi K; Tsujimoto T; Asahiyama M; Itagaki K; Tanabe S; Kato N; Amano Y
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):961-71. PubMed ID: 23462190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR145237.
    Matsuo M; Hashimoto M; Suzuki J; Iwanami K; Tomoi M; Shimomura K
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):387-92. PubMed ID: 8887456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypolipidemic action of F-1394, an acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, in high-fat diet fed beagle dogs].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Yakugaku Zasshi; 1997 Apr; 117(4):233-41. PubMed ID: 9167444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity.
    Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR
    J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical alterations in guinea pig adrenal cortex following administration of PD 132301-2, an inhibitor of acyl-CoA:cholesterol acyltransferase.
    Wolfgang GH; MacDonald JR; Vernetti LA; Pegg DG; Robertson DG
    Life Sci; 1995 Feb; 56(13):1089-93. PubMed ID: 9001442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs.
    LaPensee CR; Mann JE; Rainey WE; Crudo V; Hunt SW; Hammer GD
    Endocrinology; 2016 May; 157(5):1775-88. PubMed ID: 26986192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture.
    Junquero D; Pilon A; Carilla-Durand E; Patoiseau JF; Tarayre JP; Torpier G; Staels B; Fruchart JC; Colpaert FC; Clavey V; Delhon A
    Biochem Pharmacol; 2001 Feb; 61(4):387-98. PubMed ID: 11226372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
    Matsui Y; Horiuchi K; Yamamoto K; Kanai K
    Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicity.
    Sliskovic DR; Picard JA; O'Brien PM; Liao P; Roark WH; Roth BD; Anderson MA; Mueller SB; Bocan TM; Bousley RF; Hamelehle KL; Homan R; Reindel JF; Stanfield RL; Turluck D; Krause BR
    J Med Chem; 1998 Feb; 41(5):682-90. PubMed ID: 9513596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.